Baird Financial Group
CLOV icon

Baird Financial Group’s Clover Health Investments CLOV Stock Holding History

Baird Financial Group’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-134,000
Closed -$106K – 1768
2024
Q1 		$106K Hold
134,000
– – ﹤0.01% 1721
2023
Q4 		$128K Buy
134,000
+39,000
+41% +$38.3K ﹤0.01% 1668
2023
Q3 		$103K Buy
95,000
+1,126
+1% +$1.34K ﹤0.01% 1669
2023
Q2 		$84.2K Sell
93,874
-97
-0.1% -$86 ﹤0.01% 1660
2023
Q1 		$79.4K Buy
93,971
+40,097
+74% +$43.9K ﹤0.01% 1661
2022
Q4 		$50K Sell
53,874
-12
-0% -$16 ﹤0.01% 1666
2022
Q3 		$92K Sell
53,886
-2
-0% -$5 ﹤0.01% 1672
2022
Q2 		$115K Buy
53,888
+14
+0% +$37 ﹤0.01% 1739
2022
Q1 		$191K Buy
53,874
+25,000
+87% +$72.5K ﹤0.01% 1759
2021
Q4 		$107K Buy
+28,874
New +$177K ﹤0.01% 1852

Other funds holding CLOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Baird Financial Group's CLOV Position: Q2 2024 in Review

Baird Financial Group sold out of Clover Health Investments (CLOV) in Q2 2024, closing a stake of 134,000 shares — an estimated $106K sold.

Baird Financial Group first reported a position in CLOV in Q4 2021 and held it in 10 quarters. The position peaked at $191K in Q1 2022. 127 funds tracked by Wall St. Rank hold CLOV as of Q2 2024.

  • Baird Financial Group reported no remaining Clover Health Investments position as of Q2 2024 after selling out during the quarter.
  • Baird Financial Group sold 134,000 Clover Health Investments shares in Q2 2024, an estimated $106K.
  • Baird Financial Group first reported a position in Clover Health Investments in Q4 2021 and held it in 10 quarters.
  • Baird Financial Group's Clover Health Investments position peaked at $191K in Q1 2022.
  • 127 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2024.

Based on Baird Financial Group's 13F filing for Q2 2024, filed 14 Aug 2024.